Login
From:
BioSpace
(Uncensored)
subscribe
M&A, IPOs Snarled by Policy Reality in Q1 as Pharmas Opt for Licensing Deals - BioSpace
https://www.biospace.com/business/m-a-ipos-snarled-by-policy-reality-in-q1-as-pharmas-opt-for-licensing-deals
links
backlinks
Tagged with:
startups
featured
feature
ipo
mergers & acquisitions
data journalism
biopharm executive
M&A and IPOs got off to a quick start in 2025 only to crash into a wall of policy challenges. Upfront payment for licensing transactions, however, grew as pharmas looked for less-risky deals.
Roast topics
Find topics
Find it!
